Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic (Allo) Non-Myeloablative Stem Cell Transplantation (SCT) Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath-1H

NCT00580034 is registered in ClinicalTrials.gov with David Rizzieri, MD as lead sponsor.

NCT NCT00580034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00580034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic (Allo) Non-Myeloablative Stem Cell Transplantation (SCT) Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath-1H
Lead sponsor
David Rizzieri, MD
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2003
Completion date
April 30, 2013
Enrollment
176 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma, myelodysplasia, myeloma, solid tumors